Private Capital Management, LLC Harrow Health, Inc. Call Options Transaction History
Private Capital Management, LLC
- $770 Million
- Q1 2025
Call Options
1 transactions
Others Institutions Holding HROW
# of Institutions
175Shares Held
21.1MCall Options Held
330KPut Options Held
670K-
Opaleye Management Inc. Boston, MA3.96MShares$110 Million28.93% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$59.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$52 Million0.0% of portfolio
-
Braidwell LP Stamford, CT957KShares$26.7 Million1.56% of portfolio
-
State Street Corp Boston, MA786KShares$21.9 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $754M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...